Merrimack Pharmaceuticals, Inc

(NASDAQ:MACK)

Latest On Merrimack Pharmaceuticals, Inc (MACK):

Date/Time Type Description Signal Details
2023-05-05 02:53 ESTNewsMerrimack Pharmaceuticals GAAP EPS of $0.02N/A
2023-03-09 19:03 ESTNewsMerrimack Pharmaceuticals GAAP EPS of -$0.11N/A
2023-01-04 21:18 ESTNewsMerrimack Still Has Significant Arbitrage PotentialN/A
2022-11-09 08:17 ESTNewsMerrimack jumps 183% as partner Ipsen says pancreatic cancer trial met main goalN/A
2022-11-04 05:04 ESTNewsMerrimack Pharmaceuticals GAAP EPS of -$0.03N/A
2022-10-31 20:40 ESTNewsReturn Of The Mack: A Deeply Misunderstood Near-Term ReadoutN/A
2022-08-09 04:46 ESTNewsMerrimack Pharmaceuticals: Out For NowN/A
2022-08-05 04:53 ESTNewsMerrimack Pharmaceuticals GAAP EPS of -$0.04N/A
2022-05-06 04:50 ESTNewsMerrimack Pharmaceuticals GAAP EPS of -$0.01N/A
2021-03-12 08:04 ESTFinancialsCompany financials have been released.Neutral
2021-03-11 10:03 ESTNewsMerrimack Pharmaceuticals reports FY resultsN/A
2021-01-06 16:06 ESTFinancialsCompany financials have been released.Neutral
2020-12-03 02:38 ESTNewsMerrimack Pharma jumps 42% on bullish timeline for potential Onivyde milestone paymentN/A
2020-11-26 20:45 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 04:31 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 16:24 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 04:19 ESTFinancialsCompany financials have been released.Neutral
2020-11-05 08:40 ESTNewsMerrimack Pharmaceuticals reports Q3 resultsN/A
2020-09-26 13:19 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 05:26 ESTFinancialsCompany financials have been released.Neutral
2020-08-17 16:26 ESTInsider TradeEric Andersen has indirectly acquired of 609 shares.Buy
2020-08-17 16:26 ESTInsider TradeNoah G. Levy has indirectly acquired of 254 shares.Buy
2020-08-17 16:26 ESTInsider TradeNoah G. Levy has indirectly acquired of 354 shares.Buy
2020-08-14 09:23 ESTFinancialsCompany financials have been released.Neutral
2020-08-13 16:56 ESTInsider TradeNoah G. Levy has indirectly acquired of 834 shares.Buy
2020-08-13 16:56 ESTInsider TradeNoah G. Levy has indirectly acquired of 5,856 shares.Buy
2020-08-13 16:56 ESTInsider TradeNoah G. Levy has indirectly acquired of 1,166 shares.Buy
2020-08-13 16:56 ESTInsider TradeNoah G. Levy has indirectly acquired of 8,186 shares.Buy
2020-08-13 16:56 ESTInsider TradeEric Andersen has indirectly acquired of 2,000 shares.Buy
2020-08-13 16:56 ESTInsider TradeEric Andersen has indirectly acquired of 14,030 shares.Buy
2020-08-09 05:08 ESTFinancialsCompany financials have been released.Neutral
2020-08-07 22:11 ESTNewsMerrimack Pharmaceuticals reports Q2 resultsN/A
2020-07-31 01:35 ESTFinancialsCompany financials have been released.Neutral
2020-07-24 19:22 ESTInsider TradeNoah G. Levy has indirectly acquired of 40,488 shares.Buy
2020-07-24 19:22 ESTInsider TradeNoah G. Levy has indirectly acquired of 33,435 shares.Buy
2020-07-24 19:22 ESTInsider TradeNoah G. Levy has indirectly acquired of 56,606 shares.Buy
2020-07-24 19:22 ESTInsider TradeNoah G. Levy has indirectly acquired of 46,745 shares.Buy
2020-07-24 19:22 ESTInsider TradeEric Andersen has indirectly acquired of 33,192 shares.Buy
2020-07-24 19:22 ESTInsider TradeEric Andersen has indirectly acquired of 17,404 shares.Buy
2020-07-24 19:22 ESTInsider TradeEric Andersen has indirectly acquired of 63,903 shares.Buy
2020-07-24 19:22 ESTInsider TradeEric Andersen has indirectly acquired of 62,775 shares.Buy
2020-07-24 19:22 ESTInsider TradeGARY L CROCKER has directly disposed of 5,986 shares and currently holds 0 shares.Sell
2020-07-24 19:22 ESTInsider TradeGARY L CROCKER has directly disposed of 17,000 shares and currently holds 0 shares.Sell
2020-07-23 17:39 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 09:17 ESTFinancialsCompany financials have been released.Neutral
2020-06-26 09:16 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 05:21 ESTFinancialsCompany financials have been released.Neutral
2020-05-27 05:26 ESTFinancialsCompany financials have been released.Neutral
2020-05-10 05:11 ESTFinancialsCompany financials have been released.Neutral
2020-05-07 19:49 ESTNewsMerrimack Pharmaceuticals reports Q1 resultsN/A

About Merrimack Pharmaceuticals, Inc (MACK):

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was founded in 1993 and is headquartered in Cambridge, Massachusetts.

MACK Quotes by TradingView

See Advanced Chart

General

  • Name Merrimack Pharmaceuticals, Inc
  • Symbol MACK
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Last Split Factor1271:1000
  • Last Split Date2019-09-06
  • Fiscal Year EndDecember
  • IPO Date2012-03-29
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.merrimack.com
View More

Valuation

  • Trailing PE 65.1
  • Price/Book (Most Recent Quarter) 5.48
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Return on Assets -17%
  • Return on Equity -18%
  • Earnings Per Share $0.10
  • Revenue Per Share $0
  • Gross Profit -9100000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 93.24 million
  • EBITDA 134000
  • PEG Ratio 0.07
  • Analyst Target Price $4
  • Book Value Per Share $1.20
View More

Share Statistics

  • Shares Outstanding 13.41 million
  • Shares Float 8.11 million
  • % Held by Insiders 324%
  • % Held by Institutions 60.31%
  • Shares Short 576520
  • Shares Short Prior Month 589421
  • Short Ratio 4.24
  • Short % of Float 5%
  • Short % of Shares Outstanding 4%
View More

Technicals

  • Beta 2.48
  • 52 Week High $9.35
  • 52 Week Low $1.49
  • 50 Day Moving Average 7.2
  • 200 Day Moving Average 5.64
View More

Dividends

  • Forward Annual Dividend Yield 57.71%
  • Dividend Date 2019-12-23
  • ExDividend Date 2019-12-13
  • Dividend Per Share $1.5
  • Dividend Yield 0%
View More

Merrimack Pharmaceuticals, Inc (MACK) Dividend Calendar:

MACK's last dividend payment was made to shareholders on December 23, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Merrimack Pharmaceuticals, Inc (MACK) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-10$N/A-$0.08
2020-09-302020-12-31$N/A-$0.09
2020-06-302020-09-30$N/A-$0.08
2020-03-312020-06-30$N/A-$0.09
2019-12-312020-03-31$N/A$0.02
2019-09-302019-11-11$N/A-$0.05
2019-06-302019-09-30$N/A-$0.05
2019-03-312019-06-30$N/A-$0.71
2018-12-312019-03-31$N/A-$0.78-$0.64-22.47%
2018-09-302018-12-31$N/A-$0.96-$0.60-61.98%
2018-06-302018-08-07$N/A-$1.33-$1.28-3.52%
2018-03-312018-05-08$N/A-$1.33-$1.28-3.91%
2017-12-312018-03-12$N/A-$1.08-$1.2714.97%
2017-09-302017-11-08$N/A$0.24-$1.90112.66%
2017-06-302017-08-09$N/A$38.60-$1.382890.83%
2017-03-312017-05-10$N/A-$2.30-$1.80-28.01%
2016-12-312017-03-01$61.24 million-$2.50-$2.09-19.9%
2016-09-302016-11-09$28.07 million-$2.30-$3.0123.47%
2016-06-302016-08-04$33.68 million-$4.00-$3.30-21.21%
2016-03-312016-05-02$21.28 million-$3.30-$3.7812.58%
2015-12-312016-02-25$21.42 million-$4.10-$3.98-3.14%
2015-09-302015-11-09$16.44 million-$3.80-$4.035.71%
2015-06-302015-08-10$36.56 million-$0.21-$0.3132.26%
2015-03-312015-05-07$14.84 million-$0.32-$0.29-10.34%
2014-12-312015-02-26$33.91 million-$0.09-$0.1952.63%
2014-09-302014-11-10$28 million-$0.27-$0.12-125%
2014-06-302014-08-11$27.82 million-$1.70-$3.0043.33%
2014-03-312014-05-01$13.03 million-$2.70-$2.958.47%
2013-12-312014-02-27$7.82 million-$3.30-$2.90-13.79%
2013-09-302013-11-07$6.86 million-$3.90-$3.07-27.04%
2013-06-302013-08-08$18.45 million-$3.10-$2.77-11.91%
2013-03-312013-05-13$14.66 million-$2.90-$2.77-4.69%
2012-12-312013-03-14$14.19 million-$2.60-$2.620.76%
2012-09-302012-11-14$11.32 million-$2.50-$2.583.1%
2012-06-302012-08-10$12.06 million-$2.20-$2.7018.52%
2012-03-312012-05-15$11.34 million-$21.38

Merrimack Pharmaceuticals, Inc (MACK) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Merrimack Pharmaceuticals, Inc (MACK) Chart:

Merrimack Pharmaceuticals, Inc (MACK) News:

Below you will find a list of latest news for Merrimack Pharmaceuticals, Inc (MACK) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Merrimack Pharmaceuticals, Inc (MACK) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Merrimack Pharmaceuticals, Inc (MACK) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312520154365/0001193125-20-154365-index.htm
2019-08-12UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1274792/000000000019012332/0000000000-19-012332-index.htm
2019-08-12UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1274792/000000000019012333/0000000000-19-012333-index.htm
2019-08-15UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1274792/000000000019012527/0000000000-19-012527-index.htm
2018-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1274792/000021545718005865/0000215457-18-005865-index.htm
2019-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924319024347/0000899243-19-024347-index.htm
2019-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924319024349/0000899243-19-024349-index.htm
2019-10-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924319025789/0000899243-19-025789-index.htm
2019-10-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924319025791/0000899243-19-025791-index.htm
2019-10-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924319025794/0000899243-19-025794-index.htm
2020-04-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320010463/0000899243-20-010463-index.htm
2020-04-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320010465/0000899243-20-010465-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320010517/0000899243-20-010517-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320010518/0000899243-20-010518-index.htm
2020-04-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320011148/0000899243-20-011148-index.htm
2020-04-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320011149/0000899243-20-011149-index.htm
2020-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320020427/0000899243-20-020427-index.htm
2020-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320020428/0000899243-20-020428-index.htm
2020-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320020430/0000899243-20-020430-index.htm
2020-08-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320021044/0000899243-20-021044-index.htm
2020-08-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320021046/0000899243-20-021046-index.htm
2020-08-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320021047/0000899243-20-021047-index.htm
2020-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320022283/0000899243-20-022283-index.htm
2020-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320022284/0000899243-20-022284-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320022559/0000899243-20-022559-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320022561/0000899243-20-022561-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1274792/000090571819000208/0000905718-19-000208-index.htm
2019-05-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1274792/000090571819000433/0000905718-19-000433-index.htm
2020-07-27SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000090571820000776/0000905718-20-000776-index.htm
2018-11-02SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000092189518002918/0000921895-18-002918-index.htm
2018-12-19SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000092189518003351/0000921895-18-003351-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519000476/0000921895-19-000476-index.htm
2019-03-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000092189519000739/0000921895-19-000739-index.htm
2019-03-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519000847/0000921895-19-000847-index.htm
2019-03-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519000848/0000921895-19-000848-index.htm
2019-03-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519000849/0000921895-19-000849-index.htm
2019-03-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519000850/0000921895-19-000850-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519001055/0000921895-19-001055-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519001056/0000921895-19-001056-index.htm
2019-04-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000092189519001112/0000921895-19-001112-index.htm
2019-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519001116/0000921895-19-001116-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519001955/0000921895-19-001955-index.htm
2019-07-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519002005/0000921895-19-002005-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519002020/0000921895-19-002020-index.htm
2019-07-24SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000092189519002039/0000921895-19-002039-index.htm
2019-07-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519002049/0000921895-19-002049-index.htm
2019-08-06PREC14APreliminary proxy statements, contested solicitationshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519002103/0000921895-19-002103-index.htm
2019-08-13PRRN14ANon-management revised preliminary proxy soliciting materials, contested and otherwisehttps://www.sec.gov/Archives/edgar/data/1274792/000092189519002191/0000921895-19-002191-index.htm
2019-08-19PRRN14ANon-management revised preliminary proxy soliciting materials, contested and otherwisehttps://www.sec.gov/Archives/edgar/data/1274792/000092189519002270/0000921895-19-002270-index.htm
2019-08-22DFAN14AAdditional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1274792/000092189519002303/0000921895-19-002303-index.htm
2019-09-24DFAN14AAdditional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1274792/000092189519002451/0000921895-19-002451-index.htm
2019-09-24SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000092189519002452/0000921895-19-002452-index.htm
2019-11-19SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000092189519002823/0000921895-19-002823-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1274792/000092189520000542/0000921895-20-000542-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1274792/000110465920021226/0001104659-20-021226-index.htm
2018-07-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312518211983/0001193125-18-211983-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312518240346/0001193125-18-240346-index.htm
2018-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312518320126/0001193125-18-320126-index.htm
2019-02-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519042418/0001193125-19-042418-index.htm
2019-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519064654/0001193125-19-064654-index.htm
2019-03-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1274792/000119312519064697/0001193125-19-064697-index.htm
2019-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519107839/0001193125-19-107839-index.htm
2019-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519127241/0001193125-19-127241-index.htm
2019-04-3010-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1274792/000119312519129368/0001193125-19-129368-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519143634/0001193125-19-143634-index.htm
2019-05-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519161299/0001193125-19-161299-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519180123/0001193125-19-180123-index.htm
2019-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519186553/0001193125-19-186553-index.htm
2019-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519187371/0001193125-19-187371-index.htm
2019-07-018-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519187374/0001193125-19-187374-index.htm
2019-07-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519193279/0001193125-19-193279-index.htm
2019-07-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519195208/0001193125-19-195208-index.htm
2019-07-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519204007/0001193125-19-204007-index.htm
2019-08-05PREC14APreliminary proxy statements, contested solicitationshttps://www.sec.gov/Archives/edgar/data/1274792/000119312519213083/0001193125-19-213083-index.htm
2019-08-16DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1274792/000119312519223186/0001193125-19-223186-index.htm
2019-08-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1274792/000119312519223587/0001193125-19-223587-index.htm
2019-08-16PRER14APreliminary Proxy Soliciting materialshttps://www.sec.gov/Archives/edgar/data/1274792/000119312519223588/0001193125-19-223588-index.htm
2019-08-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1274792/000119312519229227/0001193125-19-229227-index.htm
2019-09-05DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1274792/000119312519238418/0001193125-19-238418-index.htm
2019-09-19DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1274792/000119312519249100/0001193125-19-249100-index.htm
2019-09-19SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000119312519249231/0001193125-19-249231-index.htm
2019-09-19SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000119312519249241/0001193125-19-249241-index.htm
2019-09-20PRER14APreliminary Proxy Soliciting materialshttps://www.sec.gov/Archives/edgar/data/1274792/000119312519250054/0001193125-19-250054-index.htm
2019-09-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519250720/0001193125-19-250720-index.htm
2019-09-20DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1274792/000119312519250722/0001193125-19-250722-index.htm
2019-09-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1274792/000119312519256009/0001193125-19-256009-index.htm
2019-09-26CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1274792/000119312519256019/0001193125-19-256019-index.htm
2019-09-30SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000119312519257723/0001193125-19-257723-index.htm
2019-09-30SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000119312519257726/0001193125-19-257726-index.htm
2019-10-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519270407/0001193125-19-270407-index.htm
2019-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519304912/0001193125-19-304912-index.htm
2019-12-038-A12GRegistration of securities [Section 12(g)]https://www.sec.gov/Archives/edgar/data/1274792/000119312519304913/0001193125-19-304913-index.htm
2020-02-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312520044782/0001193125-20-044782-index.htm
2020-03-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1274792/000119312520072857/0001193125-20-072857-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312520090100/0001193125-20-090100-index.htm
2020-04-10PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1274792/000119312520103890/0001193125-20-103890-index.htm
2020-04-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1274792/000119312520115075/0001193125-20-115075-index.htm
2020-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312520154365/0001193125-20-154365-index.htm
2020-07-24SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000119312520197975/0001193125-20-197975-index.htm
2020-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312520212544/0001193125-20-212544-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312520286284/0001193125-20-286284-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000120919118038075/0001209191-18-038075-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000120919118038077/0001209191-18-038077-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000120919118038080/0001209191-18-038080-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000120919118038082/0001209191-18-038082-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000120919118062433/0001209191-18-062433-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000120919118062435/0001209191-18-062435-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000120919118062437/0001209191-18-062437-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000120919118062438/0001209191-18-062438-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000120919118062440/0001209191-18-062440-index.htm
2019-05-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000120919119028674/0001209191-19-028674-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1274792/000121465919000909/0001214659-19-000909-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1274792/000125889720001153/0001258897-20-001153-index.htm
2018-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1274792/000156459018019659/0001564590-18-019659-index.htm
2018-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1274792/000156459018027759/0001564590-18-027759-index.htm
2019-03-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1274792/000156459019006385/0001564590-19-006385-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1274792/000156459019018299/0001564590-19-018299-index.htm
2019-07-1710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1274792/000156459019025092/0001564590-19-025092-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1274792/000156459019042925/0001564590-19-042925-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1274792/000156459020010531/0001564590-20-010531-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1274792/000156459020022829/0001564590-20-022829-index.htm
2020-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1274792/000156459020038076/0001564590-20-038076-index.htm
2020-11-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1274792/000156459020050520/0001564590-20-050520-index.htm

Merrimack Pharmaceuticals, Inc (MACK) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Merrimack Pharmaceuticals, Inc (MACK). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 324%
Institutional Ownership: 6031%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-07-22GARY L CROCKEROfficerSell5,986.003.0418,208.810.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320020430/0000899243-20-020430-index.htm
2020-07-22GARY L CROCKEROfficerSell17,000.003.2054,434.000.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320020430/0000899243-20-020430-index.htm
2019-07-11Jason Aryeh10% Share HolderBuy100.005.71571.00100.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519002005/0000921895-19-002005-index.htm
2019-04-0522NW, LP10% Share HolderBuy50,000.006.12305,760.001,142,263.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001056/0000921895-19-001056-index.htm
2019-04-0822NW, LP10% Share HolderBuy32,873.005.81191,034.861,175,136.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001056/0000921895-19-001056-index.htm
2019-04-1522NW, LP10% Share HolderBuy30,110.005.73172,530.301,205,246.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001116/0000921895-19-001116-index.htm
2019-04-1622NW, LP10% Share HolderBuy20,450.005.95121,636.601,225,696.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001116/0000921895-19-001116-index.htm
2019-04-1722NW, LP10% Share HolderBuy16,200.006.0097,156.261,241,896.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001116/0000921895-19-001116-index.htm
2020-07-22Eric AndersenDirectorBuy17,404.003.2055,727.61193,990.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320020428/0000899243-20-020428-index.htm
2020-07-22Eric AndersenDirectorBuy33,192.003.04100,966.74227,182.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320020428/0000899243-20-020428-index.htm
2020-08-11Eric AndersenDirectorBuy14,030.003.4548,437.17241,212.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320022284/0000899243-20-022284-index.htm
2020-08-12Eric AndersenDirectorBuy2,000.003.496,986.00243,212.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320022284/0000899243-20-022284-index.htm
2019-07-12Jason Aryeh10% Share HolderBuy2,400.005.7113,704.002,500.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519002005/0000921895-19-002005-index.htm
2019-07-12Jason Aryeh10% Share HolderBuy1,000.005.625,620.003,500.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519002005/0000921895-19-002005-index.htm
2019-07-16Jason Aryeh10% Share HolderBuy302.005.441,642.883,802.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519002020/0000921895-19-002020-index.htm
2019-04-08JFL Capital Management, LLC10% Share HolderBuy4,506.005.7325,803.16489,532.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001055/0000921895-19-001055-index.htm
2019-06-28JFL Capital Management, LLC10% Share HolderBuy9,662.005.9557,440.59499,194.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001955/0000921895-19-001955-index.htm
2020-04-03Noah G. LevyDirectorBuy4,461.002.5911,568.27500,081.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320010465/0000899243-20-010465-index.htm
2020-04-06Noah G. LevyDirectorBuy2,507.003.007,512.23502,588.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320010465/0000899243-20-010465-index.htm
2019-07-01JFL Capital Management, LLC10% Share HolderBuy3,934.006.0023,615.41503,128.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001955/0000921895-19-001955-index.htm
2020-04-07Noah G. LevyDirectorBuy2,448.003.037,421.85505,036.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320010517/0000899243-20-010517-index.htm
2020-04-20Noah G. LevyDirectorBuy965.003.253,136.25506,001.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320011149/0000899243-20-011149-index.htm
2020-04-21Noah G. LevyDirectorBuy591.003.251,920.75506,592.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320011149/0000899243-20-011149-index.htm
2019-07-02JFL Capital Management, LLC10% Share HolderBuy7,024.005.8541,076.35510,152.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001955/0000921895-19-001955-index.htm
2020-07-22Noah G. LevyDirectorBuy33,435.003.20107,058.87540,027.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320020427/0000899243-20-020427-index.htm
2020-07-22Noah G. LevyDirectorBuy40,488.003.04123,160.45580,515.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320020427/0000899243-20-020427-index.htm
2020-08-11Noah G. LevyDirectorBuy5,856.003.4520,217.84586,371.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320022283/0000899243-20-022283-index.htm
2020-08-12Noah G. LevyDirectorBuy834.003.492,913.16587,205.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320022283/0000899243-20-022283-index.htm
2020-08-13Noah G. LevyDirectorBuy254.003.50889.00587,459.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320022561/0000899243-20-022561-index.htm
2020-04-03Eric AndersenDirectorBuy10,750.002.6027,924.20677,077.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320010463/0000899243-20-010463-index.htm
2020-04-06Eric AndersenDirectorBuy6,043.003.0018,107.85683,120.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320010463/0000899243-20-010463-index.htm
2020-04-03Noah G. LevyDirectorBuy6,289.002.5916,308.63683,835.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320010465/0000899243-20-010465-index.htm
2020-04-06Noah G. LevyDirectorBuy3,535.003.0010,592.63687,370.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320010465/0000899243-20-010465-index.htm
2020-04-07Eric AndersenDirectorBuy5,899.003.0317,884.59689,019.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320010518/0000899243-20-010518-index.htm
2020-04-07Noah G. LevyDirectorBuy3,451.003.0310,462.74690,821.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320010517/0000899243-20-010517-index.htm
2020-04-20Eric AndersenDirectorBuy2,325.003.257,556.25691,344.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320011148/0000899243-20-011148-index.htm
2020-04-20Noah G. LevyDirectorBuy1,360.003.254,420.00692,181.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320011149/0000899243-20-011149-index.htm
2020-04-21Eric AndersenDirectorBuy1,424.003.254,628.00692,768.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320011148/0000899243-20-011148-index.htm
2020-04-21Noah G. LevyDirectorBuy833.003.252,707.25693,014.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320011149/0000899243-20-011149-index.htm
2019-04-05JFL Capital Management, LLC10% Share HolderBuy26,288.005.95156,466.18703,524.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001055/0000921895-19-001055-index.htm
2019-04-08JFL Capital Management, LLC10% Share HolderBuy6,484.005.7337,129.98710,008.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001055/0000921895-19-001055-index.htm
2019-06-28JFL Capital Management, LLC10% Share HolderBuy13,902.005.9582,647.39723,910.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001955/0000921895-19-001955-index.htm
2019-07-01JFL Capital Management, LLC10% Share HolderBuy5,659.006.0033,970.41729,569.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001955/0000921895-19-001955-index.htm
2019-07-02JFL Capital Management, LLC10% Share HolderBuy10,107.005.8559,105.74739,676.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001955/0000921895-19-001955-index.htm
2020-07-22Noah G. LevyDirectorBuy46,745.003.20149,677.49739,759.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320020427/0000899243-20-020427-index.htm
2020-07-22Eric AndersenDirectorBuy62,775.003.20201,005.55755,543.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320020428/0000899243-20-020428-index.htm
2020-07-22Noah G. LevyDirectorBuy56,606.003.04172,189.79796,365.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320020427/0000899243-20-020427-index.htm
2020-08-11Noah G. LevyDirectorBuy8,186.003.4528,262.17804,551.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320022283/0000899243-20-022283-index.htm
2020-08-12Noah G. LevyDirectorBuy1,166.003.494,072.84805,717.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320022283/0000899243-20-022283-index.htm
2020-08-13Noah G. LevyDirectorBuy354.003.501,239.00806,071.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320022561/0000899243-20-022561-index.htm
2020-07-22Eric AndersenDirectorBuy63,903.003.04194,386.54819,446.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320020428/0000899243-20-020428-index.htm
2020-08-13Eric AndersenDirectorBuy609.003.502,131.50820,055.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320022559/0000899243-20-022559-index.htm